Form 8-K - Current report:
SEC Accession No. 0001095981-10-000013
Filing Date
2010-06-17
Accepted
2010-06-17 15:04:16
Documents
8
Period of Report
2010-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CYTORI THERAPEUTICS FORM 8-K FILED 06-15-2010 GE LOAN cytori_8kgeloan.htm 8-K 49557
2 AMENDED LOAN AND SECURITY AGREEMENT exhibit1070.htm EX-10.70 530371
3 PROMISSORY NOTE IN FAVOR OF GECC exhibit1071.htm EX-10.71 15974
4 PROMISSORY NOTE IN FAVOR OF OXFORD exhibit1072.htm EX-10.72 16096
5 WARRANT IN FAVOR OF GECC exhibit1073.htm EX-10.73 109273
6 WARRANT IN FAVOR OF SVB exhibi1074.htm EX-10.74 105736
7 WARRANT IN FAVOR OF OXFORD exhibit1075.htm EX-10.75 105663
8 CYTORI THERAPEUTICS PRESS RELEASE 06-14-2010 exhibit991_pressrelease.htm EX-99.1 10685
  Complete submission text file 0001095981-10-000013.txt   945389
Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 8584580900
CYTORI THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 10902965
SIC: 3841 Surgical & Medical Instruments & Apparatus